Article: Treatment and follow-up of children with transient congenital hypothyroidism

Objective: To study the clinical therapy and prognosis in children with transient congenital hypothyroidism (CH).

Methods: Fifty-seven children with CH diagnosed after neonatal screening were treated with low-dosage levothyroxine (L-T4). Follow-up evaluation included the determination of TT3, TT4 and TSH serum levels and the assessment of thyroid gland morphology, bone age, growth development and development quotients (DQ). A full check-up was performed at age 2, when the affected children first discontinued the L-T4 treatment for 1 month, and one year later. Development quotients were compared with a control group of 29 healthy peers.

Results: The initial L-T4 dosage administered was 3.21-5.81 microg/(kg.d) with an average of (16.25+/-3.87) microg/d. Mean duration of therapy was (28.09+/-9.56) months. No significant difference was found between study group and control group in the DQ test (average score (106.58+/-14.40) vs (102.4+/-8.6), P>0.05) and 96.49% of the CH children achieved a test score above 85. Bone age, 99mTc scans and ultrasonographic findings were all normal, and evaluation of physical development was normal too, as were the serum levels of TT3, TT4 and TSH after one year of follow-up.

Conclusion: A L-T4 dosage of 3.21-5.81 microg/(kg.d) was found sufficient for the treatment of transient CH. The treated children showed satisfactory overall mental and physical development at age 2. So it is possible for CH children to stop taking medicine if their laboratory findings and physical development are all normal after regular treatment and 2-3 years of follow-up.

Citing Articles

To Study the Iodine Concentration of Mothers' Consumed Salt, Water, and Staple Food in the Neonatal Screening Program of Rural and Urban Vidarbha Region.

Kondhalkar A, Kaple M, Ambad R, Dhok A, Anjankar A J Pharm Bioallied Sci. 2025; 16(Suppl 4):S4041-S4044.

PMID: 39926976 PMC: 11805047. DOI: 10.4103/jpbs.jpbs_1394_24.

Etiological evaluation of primary congenital hypothyroidism cases.

Bezen D, Dilek E, Torun N, Tutunculer F Turk Pediatri Ars. 2017; 52(2):85-91.

PMID: 28747839 PMC: 5509128. DOI: 10.5152/TurkPediatriArs.2017.3989.

[Analysis of treatment efficacy for congenital hypothyroidism in some regions of Yunnan Province, China].

Yang J, Zhang J, Zhang Y, Xu X, Chen H, Li Y Zhongguo Dang Dai Er Ke Za Zhi. 2017; 19(7):741-747.

PMID: 28697824 PMC: 7389930.

Congenital Hypothyroidism: Optimal Initial Dosage and Time of Initiation of Treatment: A Systematic Review.

Rahmani K, Yarahmadi S, Etemad K, Koosha A, Mehrabi Y, Aghang N Int J Endocrinol Metab. 2016; 14(3):e36080.

PMID: 27942261 PMC: 5136456. DOI: 10.5812/ijem.36080.

The role of initial clinical and laboratory findings in infants with hyperthyrotropinemia to predict transient or permanent hypothyroidism.

Unuvar T, Demir K, Abaci A, Buyukgebiz A, Bober E J Clin Res Pediatr Endocrinol. 2013; 5(3):170-3.

PMID: 24072085 PMC: 3814532. DOI: 10.4274/Jcrpe.931.

References

1.

Rovet J, Ehrlich R . Long-term effects of L-thyroxine therapy for congenital hypothyroidism. J Pediatr. 1995; 126(3):380-6. DOI: 10.1016/s0022-3476(95)70452-3. View

2.

Hsiao P, Chiu Y, Tsai W, Su S, Lee J, Soong W . Intellectual outcome of patients with congenital hypothyroidism detected by neonatal screening. J Formos Med Assoc. 2001; 100(1):40-4. View

3.

Wang S, Pizzolato S, Demshar H . Diagnostic effectiveness of TSH screening and of T4 with secondary TSH screening for newborn congenital hypothyroidism. Clin Chim Acta. 1998; 274(2):151-8. DOI: 10.1016/s0009-8981(98)00057-6. View

4.

Salerno M, Militerni R, Bravaccio C, Micillo M, Capalbo D, Di M . Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism. Thyroid. 2002; 12(1):45-52. DOI: 10.1089/105072502753451968. View

5.

Pasquier S, Torresani T, WERDER E, Gnehm H . [Transitory neonatal hypothyroidism caused by transplacental transfer of anti-receptor antibodies of hypophyseal thyroid simulation. Case report and estimated incidence]. Schweiz Med Wochenschr. 1998; 127(44):1824-8. View

6.

Gruters A, Liesenkotter K, Zapico M, Jenner A, Dutting C, Pfeiffer E . Results of the screening program for congenital hypothyroidism in Berlin (1978-1995). Exp Clin Endocrinol Diabetes. 1997; 105 Suppl 4:28-31. DOI: 10.1055/s-0029-1211928. View

7.

Hrytsiuk I, Gilbert R, Logan S, Pindoria S, Brook C . Starting dose of levothyroxine for the treatment of congenital hypothyroidism: a systematic review. Arch Pediatr Adolesc Med. 2002; 156(5):485-91. DOI: 10.1001/archpedi.156.5.485. View

8.

Campos S, Sandberg D, BARRICK C, VOORHESS M, MACGILLIVRAY M . Outcome of lower L-thyroxine dose for treatment of congenital hypothyroidism. Clin Pediatr (Phila). 1995; 34(10):514-20. DOI: 10.1177/000992289503401001. View

9.

Gu X, Wang Z . [Screening for phenylketonuria and congenital hypothyroidism in 5.8 million neonates in China]. Zhonghua Yu Fang Yi Xue Za Zhi. 2004; 38(2):99-102. View

10.

Wasniewska M, De Luca F, Siclari S, Salzano G, Messina M, Lombardo F . Hearing loss in congenital hypothalamic hypothyroidism: a wide therapeutic window. Hear Res. 2002; 172(1-2):87-91. DOI: 10.1016/s0378-5955(02)00515-4. View

11.

Oerbeck B, Sundet K, Kase B, Heyerdahl S . Congenital hypothyroidism: influence of disease severity and L-thyroxine treatment on intellectual, motor, and school-associated outcomes in young adults. Pediatrics. 2003; 112(4):923-30. DOI: 10.1542/peds.112.4.923. View

Treatment and Follow-up of Children with Transient Congenital Hypothyroidism